Back to News
Market Impact: 0.5

Berkshire Hathaway to buy Occidental Petroleum's chemicals arm for $9.7B

OXYYBNSCVXBHLB
M&A & RestructuringCompany FundamentalsCredit & Bond MarketsAnalyst InsightsEnergy Markets & PricesCorporate EarningsManagement & Governance
Berkshire Hathaway to buy Occidental Petroleum's chemicals arm for $9.7B

Berkshire Hathaway is set to acquire Occidental Petroleum's chemicals arm, OxyChem, for $9.7 billion, marking Occidental's largest divestment to significantly reduce its $23.34 billion debt load and refocus on its core oil and gas business. While Occidental plans to use $6.5 billion of the proceeds for debt reduction, its shares fell over 6% amid analyst concerns regarding the unit's future free cash flow contribution and a valuation ($9.7B) lower than some estimates. For Berkshire, this represents its largest purchase since 2022, expanding its chemical portfolio and underscoring its close financial ties as Occidental's largest shareholder.

Analysis

Occidental Petroleum's (OXY) divestiture of its OxyChem unit to Berkshire Hathaway for $9.7 billion is a pivotal deleveraging event, directly addressing the $23.34 billion debt load accrued from its large-scale acquisitions of Anadarko and CrownRock. By allocating $6.5 billion of the proceeds to debt reduction, Occidental aims to bring its principal debt below its $15 billion target, strategically refocusing the company on its core oil and gas business, which comprised 75% of its earnings last year. However, the market's reaction was sharply negative, with OXY shares falling over 6%, reflecting investor and analyst concerns. Scotiabank noted the transaction price appeared low against their $12 billion valuation, while Roth MKM highlighted the potential for reduced free cash flow growth, as OxyChem was a material contributor with $2.42 billion in revenue in the first half of the year. For Berkshire Hathaway, this is its largest purchase since 2022, expanding its chemical portfolio and reinforcing its close financial ties as Occidental's largest shareholder.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo